Could a single dose of pneumococcal conjugate vaccine in children be effective?: Modeling the optimal age of vaccination
- 13 February 2006
- Vol. 24 (7), 904-913
- https://doi.org/10.1016/j.vaccine.2005.08.092
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- A Trial of a 9-Valent Pneumococcal Conjugate Vaccine in Children with and Those without HIV InfectionNew England Journal of Medicine, 2003
- Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trialThe Lancet, 2003
- Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate VaccineNew England Journal of Medicine, 2003
- Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infantsVaccine, 2003
- Immunogenicity after one, two or three doses and impact on the antibody response to coadministered antigens of a nonavalent pneumococcal conjugate vaccine in infants of Soweto, South AfricaThe Pediatric Infectious Disease Journal, 2002
- Reduction of Nasopharyngeal Carriage ofStreptococcus pneumoniaeafter Administration of a 9‐Valent Pneumococcal Conjugate Vaccine to Toddlers Attending Day Care CentersThe Journal of Infectious Diseases, 2002
- Estimates of world-wide distribution of child deaths from acute respiratory infectionsThe Lancet Infectious Diseases, 2002
- Active Bacterial Core Surveillance of the Emerging Infections Program NetworkEmerging Infectious Diseases, 2001
- Safety and Immunogenicity of Heptavalent Pneumococcal Vaccine Conjugated to CRM197 Among Infants With Sickle Cell DiseasePediatrics, 2000
- Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in childrenThe Pediatric Infectious Disease Journal, 2000